News Archives - Page 6 of 93

WednesdayJul 09, 2025 11:31 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Lead Program in Virtual CEO Segment

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on treating primary and metastatic cancers in the brain and central nervous system, announced CEO John Climaco’s participation in a Virtual Investor CEO Connect segment. Climaco provided an overview of the Company’s lead candidate, TPI 287, and shared insights from the Longwood Healthcare Leaders Spring 2025 Meeting in Cambridge, Massachusetts. To view the full press release, visit https://ibn.fm/cRmQS About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The…

TuesdayJul 08, 2025 2:35 pm

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Emerges from Lottery.com Rebrand with Global Sports, Entertainment and Gaming Vision

SEGG Media (NASDAQ: SEGG, LTRYW), formerly Lottery.com Inc., has completed its corporate rebrand and strategic overhaul, signaling a new era as a global sports, entertainment, and ethical gaming conglomerate. Trading under the new SEGG ticker, the company now operates across three verticals: Sports.com (live streaming, sim racing, eSports), Entertainment (event streaming, music, fashion), and Lottery.com (iGaming and charity-aligned gaming). Following a $300 million equity line, SEGG Media is focused on non-dilutive growth, asset-backed acquisitions, and fan-first digital experiences, with major initiatives expected in global motorsports, storytelling content, and branded facilities. To view the full press release, visit https://ibn.fm/4RHJC About SEGG…

TuesdayJul 08, 2025 12:18 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Featured in Editorial Highlighting Breakthrough Genetic Medicine Platform

Calidi Biotherapeutics (NYSE American: CLDI) announced its feature in a NetworkNewsWire editorial discussing the company’s precision genetic medicine platform, which targets both primary and metastatic cancer tumors using engineered viruses. With global cancer diagnoses expected to reach 35 million annually by 2050, Calidi’s approach represents a potential breakthrough in addressing critical unmet needs. The company’s platform aims to deliver potent genetic therapies directly to cancer sites, offering a novel and potentially disruptive solution in the fight against cancer. To view the full press release, visit: https://ibn.fm/wj9TN About Calidi Biotherapeutics Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology designed…

TuesdayJun 24, 2025 2:46 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with high unmet medical needs, announced new preclinical data showing that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation. The compound demonstrated a dose-dependent and statistically significant reduction in pro-inflammatory cytokines IL-6, IL-1β, IL-2, KC/Gro, and inflammasome marker NLRP3—key factors in Alzheimer’s disease progression. Notably, the effects were independent of amyloid beta or tau pathology, highlighting INM-901’s broader potential in treating neurodegenerative diseases. The orally administered compound also targets CB1/CB2 receptors and PPARs and has shown improvements in cognition and behavior in long-term animal…

WednesdayJun 18, 2025 2:23 pm

TinyGemsBreaks – Authentic Holdings (OTC: AHRO) Subsidiary Maybacks Global Launches Hit Broadcast of Ring of Combat via Swerve TV

Authentic Holdings (OTC: AHRO) announced a major licensing agreement between its subsidiary Maybacks Global Entertainment, LLC and Swerve TV, marked by a successful debut broadcast of "Ring of Combat" from the Tropicana in Atlantic City on June 13. The event exceeded expectations, drawing substantial viewership and social media traction across Swerve TV's extensive platform, which reaches 80% of U.S. and Canadian households and over 5 million combat sports fans. The collaboration showcased the legacy of "Ring of Combat," a promotion known for launching 165 fighters into the UFC, including champions like Matt Serra and Merab Dvalishvili. The broadcast success has…

ThursdayJun 05, 2025 1:39 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Unveils Promising Data on CLD-401 at ASCO 2025

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to deliver genetic payloads. The company unveiled promising new data on its lead RedTail platform candidate, CLD-401, at the American Society of Clinical Oncology (“ASCO”) Annual Meeting. The announcement reads, “Calidi has previously demonstrated its pioneering efforts in developing an enveloped form of its proprietary oncolytic virus that is significantly more resistant to immune clearance than non-enveloped forms, allowing for systemic delivery and efficacy in syngeneic tumor-bearing pre-clinical models. Calidi has further advanced this technology with CLD-401, its first…

TuesdayJun 03, 2025 11:35 am

TinyGemsBreaks – ECGI Holdings Inc. (OTC: ECGI) Backs AI-Focused Startup TrueToForm in First Uplist Ventures Deal

ECGI Holdings (OTC: ECGI), a diversified holding company targeting innovation-led sectors, announced that its investment arm, Uplist Ventures, has completed its first deal by backing AI and 3D computer vision startup TrueToForm. The startup, also backed by MassChallenge, Dartmouth Angels, and Chicago Booth Angels, offers a patented AI body scanning platform designed to reduce e-commerce apparel returns—a $38 billion problem—by creating 97%-accurate digital avatars. ECGI’s own Pacific Saddlery brand already uses TrueToForm for custom fittings. With over 50 clients and a pipeline of 25 brands, TrueToForm is scaling fast. ECGI executives said the deal signals the company’s strategy to support…

TuesdayMay 27, 2025 11:36 am

TinyGemsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Passing of CEO Charles M. Fernandez, Appoints Interim Leadership

NextPlat (NASDAQ: NXPL, NXPLW) announced with deep sadness the sudden passing of Executive Chairman and CEO Charles M. Fernandez on May 24. Fernandez had led the company since July 2021. The Board has appointed Rodney Barreto, Chair of the Audit Committee, as Interim Chairman, and David Phipps, current President and CEO of Global Operations, as Interim CEO. Vice Chairman Doug Ellenoff expressed condolences, noting Fernandez’s dedication to family and the company. Barreto, a director since 2022, brings over 35 years of business and civic leadership, while Phipps previously led NextPlat through its early growth and Nasdaq listing. The company is…

TuesdayMay 27, 2025 10:16 am

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 6.9 MW Community Solar Project in Nova Scotia

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will develop the 6.9 MW DC Brooklyn solar project in Nova Scotia under Canada’s first Community Solar Program. Owned by AI Renewable Fund, the $13.9 million project will be built in partnership with local firm Trimac Engineering. The program supports Nova Scotia’s goal of reaching 80% renewable energy by 2030 and net-zero by 2035. SolarBank will oversee interconnection, permitting, and design through 2025, with construction expected to begin in spring 2026. The company also disclosed a shares-for-services agreement with an independent advisor valued at up to…

FridayMay 16, 2025 2:20 pm

TinyGemsBreaks – Capstone Holding Corp. (NASDAQ: CAPS) Reaffirms 2025 Guidance, Highlights M&A Pipeline and Flexible Growth Strategy

Capstone Holding (NASDAQ: CAPS)  reaffirmed its 2025 targets of a $100 million revenue run-rate and $10 million in adjusted EBITDA, supported by a strong M&A pipeline and disciplined cost control. The company is evaluating acquisition opportunities at 4–6x EBITDA multiples, with up to 45% non-cash consideration, and has secured an equity line of credit to support deals without upfront dilution. Subsidiary Instone remained on track despite seasonal headwinds, with cost run-rate guidance intact and growth expected to pick up in Q3. To view the full press release, visit https://ibn.fm/kwEhl About Capstone Holding Corp. Capstone Holding Corp. (NASDAQ: CAPS) is a…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News